Inpatient Update

In this episode of Inpatient Update , Dr. Mason Turner is joined by hospitalist Dr. Daniel Hardgrove to rethink two common fluid decisions: Acute pancreatitis — should aggressive IV fluids still be the default? LR vs normal saline — does balanced crystalloid actually improve outcomes? Practical take-homes, real-world discussion, and what to change on rounds tomorrow. Articles & PubMed Links Ag...

Semi-Annual Recap Episode In this special episode of Inpatient Update , Dr. Mason Turner looks back at the first 10 episodes and distills the biggest practice-changing lessons from more than 25 recent studies. If you're new to the show, this is the fastest way to understand what Inpatient Update is all about: practical evidence that changes what hospitalists do on rounds tomorrow. From pneumo...

With Special Guest Dr. Bianca Farley In this episode of Inpatient Update , Dr. Mason Turner is joined by hospitalist Dr. Bianca Farley to examine two practices driven largely by fear of rare but devastating complications: Are we correcting severe hyponatremia too cautiously?   Does pharmacologic DVT prophylaxis improve outcomes that actually matter to patients?   Two common hospitalist decisions....

With Special Guest Dr. Ernest Murray In this episode of Inpatient Update , Dr. Mason Turner is joined by hospitalist Dr. Ernest Murray to challenge two common antibiotic reflexes in hospital medicine: Do hospitalized patients with community-acquired pneumonia really need 5–7 days of antibiotics? Do we need to panic about QT prolongation every time we prescribe ciprofloxacin? Two everyday prescribi...

With Special Guest Dr. Adam Jaffe In this episode of Inpatient Update , Dr. Mason Turner is joined by hospitalist Dr. Adam Jaffe to tackle two high-impact clinical questions: Is there a clear winner among DOACs?   Who actually benefits from steroids in community-acquired pneumonia?   Two common decisions. New data. Practice-changing implications.  Articles & PubMed Links Apixaban vs Rivaroxaba...

With Special Guest Dr. Austin White In this episode of Inpatient Update , Dr. Mason Turner is joined by hospitalist Dr. Austin White to tackle two everyday controversies that affect nearly every admission: Asymptomatic inpatient hypertension — are PRN antihypertensives helping… or harming?  Antibiotics for pneumonia with a positive viral panel — do these patients actually benefit?  Practical take-...

With Special Guest Dr. Emily Reams In this special episode of Inpatient Update , Dr. Mason Turner is joined by hospitalist Dr. Emily Reams to break down the most practice-changing takeaways from SHM Converge 2026. No fluff — just what you can start doing on rounds tomorrow. Topics include:  Flu shots in heart failure — real mortality benefit   Stopping aspirin in patients on DOACs   Anticoagulatio...

Episode 5: De-escalating Sepsis Antibiotics & When to Pull the IV w/ Nicholas Linde, PA With Special Guest Nicholas Linde, PA In this episode of Inpatient Update , Dr. Mason Turner is joined by hospitalist PA Nick Linde to tackle two everyday decisions that impact nearly every inpatient service: De-escalating broad-spectrum antibiotics in sepsis — is it safe to stop vancomycin and zosyn earlie...

Episode 4: Faster Hypernatremia Correction & Long-Acting Antibiotics for Staph Bacteremia With Special Guest Dr. Kevin Baker In this episode of Inpatient Update , Dr. Mason Turner is joined by hospitalist Dr. Kevin Baker to discuss two studies that challenge long-held dogma in inpatient medicine: Faster correction of hypernatremia — is the traditional “go slow” rule actually harming patients?...

In this episode of Inpatient Update , Dr. Mason Turner is joined by Dr. Andres Ospina, fellow hospitalist, to discuss two recent trials with immediate impact on hospital practice: Aspirin plus anticoagulation in chronic coronary disease (AQUATIC Trial) — does keeping aspirin help or harm when long-term anticoagulation is started? Seven vs fourteen days of antibiotics for bloodstream infection (BAL...

In Episode 2 of Inpatient Update , your host, Dr. Mason Turner, breaks down three studies that could change what you do on rounds tomorrow: Phenobarbital for alcohol withdrawal — fewer admissions and shorter ED stays during the IV lorazepam shortage natural experiment. Conservative dialysis in AKI requiring RRT (LIBERATE-D) — less routine dialysis, more kidney recovery? Postoperative transfusion t...

In this pilot episode of Inpatient Update , your host, Dr. Mason Turner, breaks down three clinically relevant studies that could change how you practice tomorrow on the wards: Pre-ERCP antibiotic prophylaxis — does it reduce post-procedure infections in biliary obstruction? Reduced-dose apixaban after 6 months in cancer-associated VTE — noninferior and potentially safer? Early initiation of beta-...